Design and In Silico Evaluation of Novel 1,3,4-Oxadiazole Derivatives As Potential CYP51B Inhibitors Against Aspergillus Fumigatus. AJPS 2026, 26 (3), 302-315. https://doi.org/10.32947/ajps.v26i3.1420.